FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986131348> ?p ?o ?g. }

• W1986131348 endingPage "152" @default.
• W1986131348 startingPage "144" @default.
• W1986131348 abstract "Objective. The 2007 National Heart, Lung, and Blood Institute (NHLBI) asthma guidelines shifted the focus of care from asthma severity to ongoing assessment of asthma control using the components of impairment and risk. We evaluated the effect of omalizumab on asthma control in patients with persistent allergic asthma inadequately controlled with NHLBI Step 4 or above asthma therapy. Methods. In this double-blind, placebo-controlled study, patients ≥12 years (n = 271) received omalizumab (n = 136) or placebo (n = 135) every 2 or 4 weeks for 24 weeks. The primary efficacy variable, change from baseline in Asthma Control Test (ACT) total score, and Investigator’s Global Evaluation of Treatment Effectiveness (IGETE, secondary efficacy variable) were evaluated at week 24. Results. ACT score improved more with omalizumab compared with placebo (least squares means [LSMs]: 5.01, 4.36); however, the difference was not significant (p = .1779). Similarly, IGETE was not significantly different (p = .1177), but more patients treated with omalizumab (26/127, 20%) compared with placebo (19/131, 15%) had IGETE rated as “Excellent.” Significant benefits were observed for omalizumab compared with placebo for change in ACT score (LSMs: 6.66, 5.27; p = .0334) and IGETE (p = .0321) at week 24 in a subgroup of patients with very poorly controlled asthma (ACT ≤ 15) at baseline. There were no significant differences for the subgroup of patients with forced expiratory volume in 1 second ≤ 80% predicted at baseline. Adverse events (AEs) were similar between groups with no drug-related serious AEs or deaths. Conclusions. For allergic asthma patients with NHLBI Step 4 or above asthma therapy, omalizumab consistently improved asthma control; however, compared with placebo, differences were not significant. Placebo-treated patients had substantial improvement in their ACT score, which may have limited the ability to detect differences between treatment groups. Subgroup analyses showed significant improvements with omalizumab versus placebo in patients with very poorly controlled asthma." @default.
• W1986131348 created "2016-06-24" @default.
• W1986131348 creator A5029626136 @default.
• W1986131348 creator A5047368502 @default.
• W1986131348 creator A5078158480 @default.
• W1986131348 creator A5078421326 @default.
• W1986131348 date "2012-01-25" @default.
• W1986131348 modified "2023-09-25" @default.
• W1986131348 title "A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effect of Omalizumab on Asthma Control in Patients with Persistent Allergic Asthma" @default.
• W1986131348 cites W1570824340 @default.
• W1986131348 cites W1967215794 @default.
• W1986131348 cites W1985909983 @default.
• W1986131348 cites W1985927055 @default.
• W1986131348 cites W2014468450 @default.
• W1986131348 cites W2025406235 @default.
• W1986131348 cites W2031304864 @default.
• W1986131348 cites W2048414040 @default.
• W1986131348 cites W2052964952 @default.
• W1986131348 cites W2057611695 @default.
• W1986131348 cites W2064393916 @default.
• W1986131348 cites W2072879374 @default.
• W1986131348 cites W2086325363 @default.
• W1986131348 cites W2086332783 @default.
• W1986131348 cites W2095596518 @default.
• W1986131348 cites W2097981132 @default.
• W1986131348 cites W2110052844 @default.
• W1986131348 cites W2114257611 @default.
• W1986131348 cites W2116169865 @default.
• W1986131348 cites W2134510352 @default.
• W1986131348 cites W2137373998 @default.
• W1986131348 cites W2146852572 @default.
• W1986131348 cites W2154974655 @default.
• W1986131348 cites W2168922709 @default.
• W1986131348 cites W2601675613 @default.
• W1986131348 cites W2616424562 @default.
• W1986131348 cites W4237970589 @default.
• W1986131348 doi "https://doi.org/10.3109/02770903.2011.648296" @default.
• W1986131348 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22277052" @default.
• W1986131348 hasPublicationYear "2012" @default.
• W1986131348 type Work @default.
• W1986131348 sameAs 1986131348 @default.
• W1986131348 citedByCount "49" @default.
• W1986131348 countsByYear W19861313482012 @default.
• W1986131348 countsByYear W19861313482013 @default.
• W1986131348 countsByYear W19861313482014 @default.
• W1986131348 countsByYear W19861313482015 @default.
• W1986131348 countsByYear W19861313482016 @default.
• W1986131348 countsByYear W19861313482017 @default.
• W1986131348 countsByYear W19861313482018 @default.
• W1986131348 countsByYear W19861313482019 @default.
• W1986131348 countsByYear W19861313482020 @default.
• W1986131348 countsByYear W19861313482021 @default.
• W1986131348 countsByYear W19861313482022 @default.
• W1986131348 countsByYear W19861313482023 @default.
• W1986131348 crossrefType "journal-article" @default.
• W1986131348 hasAuthorship W1986131348A5029626136 @default.
• W1986131348 hasAuthorship W1986131348A5047368502 @default.
• W1986131348 hasAuthorship W1986131348A5078158480 @default.
• W1986131348 hasAuthorship W1986131348A5078421326 @default.
• W1986131348 hasConcept C126322002 @default.
• W1986131348 hasConcept C141105273 @default.
• W1986131348 hasConcept C142724271 @default.
• W1986131348 hasConcept C159654299 @default.
• W1986131348 hasConcept C197934379 @default.
• W1986131348 hasConcept C203014093 @default.
• W1986131348 hasConcept C204787440 @default.
• W1986131348 hasConcept C27081682 @default.
• W1986131348 hasConcept C2776042228 @default.
• W1986131348 hasConcept C2778564945 @default.
• W1986131348 hasConcept C3020633164 @default.
• W1986131348 hasConcept C71924100 @default.
• W1986131348 hasConceptScore W1986131348C126322002 @default.
• W1986131348 hasConceptScore W1986131348C141105273 @default.
• W1986131348 hasConceptScore W1986131348C142724271 @default.
• W1986131348 hasConceptScore W1986131348C159654299 @default.
• W1986131348 hasConceptScore W1986131348C197934379 @default.
• W1986131348 hasConceptScore W1986131348C203014093 @default.
• W1986131348 hasConceptScore W1986131348C204787440 @default.
• W1986131348 hasConceptScore W1986131348C27081682 @default.
• W1986131348 hasConceptScore W1986131348C2776042228 @default.
• W1986131348 hasConceptScore W1986131348C2778564945 @default.
• W1986131348 hasConceptScore W1986131348C3020633164 @default.
• W1986131348 hasConceptScore W1986131348C71924100 @default.
• W1986131348 hasIssue "2" @default.
• W1986131348 hasLocation W19861313481 @default.
• W1986131348 hasLocation W19861313482 @default.
• W1986131348 hasOpenAccess W1986131348 @default.
• W1986131348 hasPrimaryLocation W19861313481 @default.
• W1986131348 hasRelatedWork W1986131348 @default.
• W1986131348 hasRelatedWork W2042028738 @default.
• W1986131348 hasRelatedWork W2051805098 @default.
• W1986131348 hasRelatedWork W2128002469 @default.
• W1986131348 hasRelatedWork W2320940503 @default.
• W1986131348 hasRelatedWork W2326375297 @default.
• W1986131348 hasRelatedWork W2550157314 @default.
• W1986131348 hasRelatedWork W2551341492 @default.
• W1986131348 hasRelatedWork W2810305518 @default.
• W1986131348 hasRelatedWork W3109442128 @default.

• next